免疫蛍光アッセイの世界市場レポート 2025年

免疫蛍光アッセイの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.7％で54億米ドルに成長します。予測期間の成長は、個別化医療の増加、感染症サーベイランスの増加、自己免疫疾患の増加、ポイントオブケア検査の増加、世界の健康への備えの増加に起因しています。予測期間の主な動向には、多重化アッセイ、自動化・ロボット化、ハイコンテンツイメージング、先端蛍光色素、デジタル病理統合などがあります。

免疫蛍光アッセイ市場の堅調な成長は、慢性疾患の有病率の増加に大きく起因しています。ライフスタイルの変化、食習慣、不適切な体重管理は慢性疾患の急増に寄与し、感染症の長期化はがん発症のリスクをもたらします。免疫蛍光アッセイは、慢性疾患の診断や医薬品開発に幅広く使用されているため、需要が高まっています。米国疾病予防管理センターの調査によると、米国では成人の10人に6人が慢性疾患に罹患しており、その年間ヘルスケアコストは3兆8,000億米ドルに上ります。従って、慢性疾患の蔓延は、予測期間を通じて免疫蛍光アッセイの需要を促進すると予想されます。

免疫蛍光アッセイ市場は、個別化医療に対する需要の高まりにより、さらなる成長が見込まれています。個別化医療は、個人の遺伝子プロファイルを利用して、病気の予防、診断、治療に関連する意思決定に情報を提供するものであり、免疫蛍光アッセイに大きく依存しています。これらのアッセイは、個別化治療計画の策定に不可欠な特定のバイオマーカーを同定する上で極めて重要な役割を果たしています。個別化医療連合（Personalized Medicine Coalition）の報告によると、75,000を超える遺伝子検査製品と300を超える個別化医薬品が、がん、希少遺伝子疾患、慢性疾患、感染症など様々な疾患に対して利用可能になるといいます。その結果、個別化医療に対する需要の高まりが、免疫蛍光アッセイ市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界成長分析と戦略分析フレームワーク

• 世界の免疫蛍光アッセイ PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の免疫蛍光アッセイ市場成長率分析
• 世界の免疫蛍光アッセイ市場の実績：規模と成長, 2019-2024
• 世界の免疫蛍光アッセイ市場の予測：規模と成長, 2024-2029, 2034F
• 世界の免疫蛍光アッセイ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の免疫蛍光アッセイ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接免疫蛍光法
• 間接免疫蛍光法
• 世界の免疫蛍光アッセイ市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬
• 機器
• 抗体
• キット
• 消耗品およびアクセサリ
• 世界の免疫蛍光アッセイ市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん
• 感染症
• 心血管疾患
• 自己免疫疾患
• その他の病気
• 世界の免疫蛍光アッセイ市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術研究機関
• 製薬およびバイオテクノロジー企業
• 受託研究機関
• 病院および診断センター
• 世界の免疫蛍光アッセイ市場：直接免疫蛍光法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステップ直接アッセイ
• マルチプレックス直接アッセイ
• 世界の免疫蛍光アッセイ市場：間接免疫蛍光法のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルステップ間接アッセイ
• マルチプレックス間接アッセイ

第7章 地域別・国別分析

• 世界の免疫蛍光アッセイ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の免疫蛍光アッセイ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 免疫蛍光アッセイ市場：競合情勢
• 免疫蛍光アッセイ市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abcam plc Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Werfen Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Merck KGaA
• Danaher Corporation
• Cell Signaling Technology Inc.
• Vector Laboratories Inc.
• INOVA Diagnostics Inc.
• Sino Biological Inc.
• Medipan GmbH
• BioLegend Inc.
• Jackson ImmunoResearch Laboratories Inc.
• Rockland Immunochemicals Inc.
• Bethyl Laboratories Inc.
• Fitzgerald Industries International Inc.
• Creative Diagnostics
• Boster Biological Technology
• Acris Antibodies GmbH

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 免疫蛍光アッセイ市場2029年-最も新しい機会を提供する国
• 免疫蛍光アッセイ市場2029年-最も新しい機会を提供するセグメント
• 免疫蛍光アッセイ市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Immunofluorescence assay encompasses both equipment and consumables designed to utilize a technique allowing the visualization of specific proteins and antigens in infected cells. This visualization is achieved through the reaction of these proteins and antigens with specific antibodies, which are chemically conjugated with a fluorescent dye. This laboratory technique is employed in the diagnosis of diseases affecting various organ systems such as the skin, kidney, heart, cilia, and others.

The main types of immunofluorescence assay include direct immunofluorescence and indirect immunofluorescence. Direct immunofluorescence is a laboratory technique specifically used for diagnosing diseases related to the skin, kidney, and other organ systems. In this method, a single antibody directly conjugated to a fluorescent dye is utilized. The diverse range of products in the immunofluorescence assay category includes reagents, instruments, antibodies, kits, consumables, and accessories. These products are employed in the diagnosis of various diseases, including cancer, infectious diseases, autoimmune diseases, among others. Immunofluorescence assay products are utilized by academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic centers, as well as contract research organizations.

The immunofluorescence assay market research report is one of a series of new reports from The Business Research Company that provides immunofluorescence assay market statistics, including immunofluorescence assay industry global market size, regional shares, competitors with an immunofluorescence assay market share, detailed immunofluorescence assay market segments, market trends and opportunities, and any further data you may need to thrive in the immunofluorescence assay industry. This immunofluorescence assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunofluorescence assay market size has grown strongly in recent years. It will grow from $3.34 billion in 2024 to $3.59 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased disease diagnosis, rise in research and development, rise in autoimmune diseases, increased cancer diagnostics, rise in virology research.

The immunofluorescence assay market size is expected to see rapid growth in the next few years. It will grow to $5.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing personalized medicine, rising infectious disease surveillance, rising autoimmune disorders, rising point-of-care testing, increasing global health preparedness. Major trends in the forecast period include multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, digital pathology integration.

The robust growth of the immunofluorescence assay market is significantly attributed to the increasing prevalence of chronic diseases. Lifestyle changes, dietary habits, and inadequate weight management contribute to a surge in chronic conditions, with prolonged infections posing a risk of developing cancer. Immunofluorescence assays are witnessing heightened demand for their extensive use in the diagnosis and drug development activities associated with chronic diseases. A study from the Centers for Disease Control and Prevention reveals that around 6 in 10 adults in the USA are affected by chronic diseases, accounting for a substantial annual healthcare cost of $3.8 trillion. Therefore, the escalating prevalence of chronic diseases is anticipated to drive the demand for immunofluorescence assays throughout the forecast period.

The immunofluorescence assay market is poised for further growth due to the increasing demand for personalized medicines. Personalized medicine, utilizing an individual's genetic profile to inform decisions related to disease prevention, diagnosis, and treatment, relies heavily on immunofluorescence assays. These assays play a pivotal role in identifying specific biomarkers crucial for formulating personalized treatment plans. The Personalized Medicine Coalition reports that over 75,000 genetic testing products and 300 personalized medicines will be available for various conditions, including cancer, rare genetic diseases, and chronic and infectious diseases. Consequently, the rising demand for personalized medicines is propelling the growth of the immunofluorescence assay market.

A prominent trend in the immunofluorescence assay market is the emphasis on technological advancements. Companies in this sector are dedicated to developing innovative products with advanced technologies, especially for diagnostic purposes related to emerging viruses like COVID-19. LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for its microfluidic immunofluorescence assay, LumiraDx SARS-CoV-2 Ag Test, designed for the qualitative detection of nucleocapsid protein antigens from nasal swab samples in March 2022.

Major players in the immunofluorescence assay market are strategically focusing on introducing fully automated solutions to maximize their market revenues. Fully automated solutions streamline the entire immunofluorescence testing process, from sample preparation to incubation, washing, and slide mounting. Revvity Inc., a US-based life sciences and diagnostics company, launched UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics in June 2023. UNIQO 160, a tabletop device, integrates automated processing with a high-quality microscope, capable of handling up to 160 main samples and 18 slides in a single run. The system utilizes barcode recognition for individual samples, reagents, and slides.

In January 2022, Thermo Fisher Scientific Inc., a US-based biotechnology firm, acquired PeproTech Inc. for $1.85 billion. This acquisition is intended to enhance Thermo Fisher Scientific Inc.'s ability to support its pharmaceutical and biotech clients by integrating new capabilities into its biosciences business, which is essential for the changing landscape of gene therapies. PeproTech Inc. is a US-based life science company that offers recombinant proteins and ELISA immunofluorescence kits.

Major companies operating in the immunofluorescence assay market include Thermo Fisher Scientific Inc., Abcam plc, Bio-Rad Laboratories Inc., PerkinElmer Inc., Werfen Company, Merck KGaA, Danaher Corporation, Cell Signaling Technology Inc., Vector Laboratories Inc., INOVA Diagnostics Inc., Sino Biological Inc., Medipan GmbH, BioLegend Inc., Jackson ImmunoResearch Laboratories Inc., Rockland Immunochemicals Inc., Bethyl Laboratories Inc., Fitzgerald Industries International Inc., Creative Diagnostics, Boster Biological Technology, Acris Antibodies GmbH, RayBiotech Inc., Proteintech Group Inc., Novus Biologicals LLC, R&D Systems Inc., OriGene Technologies Inc., GenScript Biotech Corporation, MBL International Corporation, Abnova Corporation, Cellabs India Technologies Limited, J. Mitra & Co. Pvt. Ltd., EpiGentek Group Inc., Elabscience Biotechnology Co. Ltd., Aesku.Diagnostics GmbH

North America was the largest region in the immunofluorescence assay market in 2024, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the immunofluorescence assay market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunofluorescence assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The immunofluorescence assay market consists of sales of indirect IF complement-fixation (IF-CF), and double IF. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunofluorescence Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunofluorescence assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunofluorescence assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunofluorescence assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Direct Immunofluorescence; Indirect Immunofluorescence
• 2) By Product: Reagents; Instruments; Antibodies; Kits; Consumables and Accessories
• 3) By Disease: Cancer; Infectious Disease; Cardiovascular Diseases; Autoimmune Diseases; Other Diseases
• 4) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Hospitals And Diagnostic Centers
• Subsegments:
• 1) By Direct Immunofluorescence: Single-Step Direct Assays; Multiplex Direct Assays
• 2) By Indirect Immunofluorescence: Single-Step Indirect Assays; Multiplex Indirect Assays
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abcam plc; Bio-Rad Laboratories Inc.; PerkinElmer Inc.; Werfen Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunofluorescence Assay Market Characteristics

3. Immunofluorescence Assay Market Trends And Strategies

4. Immunofluorescence Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Immunofluorescence Assay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunofluorescence Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunofluorescence Assay Market Growth Rate Analysis
• 5.4. Global Immunofluorescence Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunofluorescence Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunofluorescence Assay Total Addressable Market (TAM)

6. Immunofluorescence Assay Market Segmentation

• 6.1. Global Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Immunofluorescence
• Indirect Immunofluorescence
• 6.2. Global Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Instruments
• Antibodies
• Kits
• Consumables and Accessories
• 6.3. Global Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Infectious Disease
• Cardiovascular Diseases
• Autoimmune Diseases
• Other Diseases
• 6.4. Global Immunofluorescence Assay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutions
• Pharmaceutical And Biotechnology Companies
• Contract Research Organizations
• Hospitals And Diagnostic Centers
• 6.5. Global Immunofluorescence Assay Market, Sub-Segmentation Of Direct Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Step Direct Assays
• Multiplex Direct Assays
• 6.6. Global Immunofluorescence Assay Market, Sub-Segmentation Of Indirect Immunofluorescence, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Step Indirect Assays
• Multiplex Indirect Assays

7. Immunofluorescence Assay Market Regional And Country Analysis

• 7.1. Global Immunofluorescence Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunofluorescence Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunofluorescence Assay Market

• 8.1. Asia-Pacific Immunofluorescence Assay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunofluorescence Assay Market

• 9.1. China Immunofluorescence Assay Market Overview
• 9.2. China Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunofluorescence Assay Market

• 10.1. India Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunofluorescence Assay Market

• 11.1. Japan Immunofluorescence Assay Market Overview
• 11.2. Japan Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunofluorescence Assay Market

• 12.1. Australia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunofluorescence Assay Market

• 13.1. Indonesia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunofluorescence Assay Market

• 14.1. South Korea Immunofluorescence Assay Market Overview
• 14.2. South Korea Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunofluorescence Assay Market

• 15.1. Western Europe Immunofluorescence Assay Market Overview
• 15.2. Western Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunofluorescence Assay Market

• 16.1. UK Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunofluorescence Assay Market

• 17.1. Germany Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunofluorescence Assay Market

• 18.1. France Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunofluorescence Assay Market

• 19.1. Italy Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunofluorescence Assay Market

• 20.1. Spain Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunofluorescence Assay Market

• 21.1. Eastern Europe Immunofluorescence Assay Market Overview
• 21.2. Eastern Europe Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunofluorescence Assay Market

• 22.1. Russia Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunofluorescence Assay Market

• 23.1. North America Immunofluorescence Assay Market Overview
• 23.2. North America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunofluorescence Assay Market

• 24.1. USA Immunofluorescence Assay Market Overview
• 24.2. USA Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunofluorescence Assay Market

• 25.1. Canada Immunofluorescence Assay Market Overview
• 25.2. Canada Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunofluorescence Assay Market

• 26.1. South America Immunofluorescence Assay Market Overview
• 26.2. South America Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunofluorescence Assay Market

• 27.1. Brazil Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunofluorescence Assay Market

• 28.1. Middle East Immunofluorescence Assay Market Overview
• 28.2. Middle East Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunofluorescence Assay Market

• 29.1. Africa Immunofluorescence Assay Market Overview
• 29.2. Africa Immunofluorescence Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunofluorescence Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Immunofluorescence Assay Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunofluorescence Assay Market Competitive Landscape And Company Profiles

• 30.1. Immunofluorescence Assay Market Competitive Landscape
• 30.2. Immunofluorescence Assay Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abcam plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Werfen Company Overview, Products and Services, Strategy and Financial Analysis

31. Immunofluorescence Assay Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. Danaher Corporation
• 31.3. Cell Signaling Technology Inc.
• 31.4. Vector Laboratories Inc.
• 31.5. INOVA Diagnostics Inc.
• 31.6. Sino Biological Inc.
• 31.7. Medipan GmbH
• 31.8. BioLegend Inc.
• 31.9. Jackson ImmunoResearch Laboratories Inc.
• 31.10. Rockland Immunochemicals Inc.
• 31.11. Bethyl Laboratories Inc.
• 31.12. Fitzgerald Industries International Inc.
• 31.13. Creative Diagnostics
• 31.14. Boster Biological Technology
• 31.15. Acris Antibodies GmbH

32. Global Immunofluorescence Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunofluorescence Assay Market

34. Recent Developments In The Immunofluorescence Assay Market

35. Immunofluorescence Assay Market High Potential Countries, Segments and Strategies

• 35.1 Immunofluorescence Assay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunofluorescence Assay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunofluorescence Assay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer